Aptiv PLC
APTV · Consumer Cyclical
$45.18
Φόρτωση γραφήματος…
Νέα
Τελευταίοι τίτλοι για αυτή τη μετοχή
Aptiv Director Agnevall Buys 4,100 Shares
Aptiv Director Hakan Agnevall purchased 4,100 shares at $48.58 per share on August 13, 2026, increasing his direct holdings by 30% to 17,797 shares. Despite the stock declining 33% over the past 12 months due to program delays and China market weakness, the insider purchase signals confidence in the company. Analysts remain bullish with 87% rating it as a buy and a median price target of $65.50, representing a 44% upside potential.
New Strong Sell Stocks for August 28th
Zacks has added three stocks to its Strong Sell list today: AngloGold Ashanti (gold mining), Aptiv PLC (industrial technology), and Boston Scientific Corporation (medical devices). All three companies have experienced downward revisions to their current year earnings estimates over the last 60 days, with Aptiv seeing the largest revision at 10.1% downward.